Results 191 to 200 of about 139,558 (270)

Using an automated decision support tool to improve HIV prescribing: A feasibility study

HIV Medicine, Volume 26, Issue 6, Page 914-922, June 2025.
Abstract Objectives The selection of antiretroviral therapy (ART) regimens for people living with HIV is complex and dependent on individual and clinician‐perceived risk factors and preferences. The British HIV Association (BHIVA) advocates cost‐effective prescribing and shared decision‐making between patients and clinicians.
Aidan T. Ireland, Jennifer Ward, Heather Dolby, Christopher Lawrence   +3 more
wiley   +1 more source

Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level Viremia. [PDF]

J Acquir Immune Defic Syndr
Calza L, Colangeli V, Giglia M, Rigamonti C, Bon I, Cretella S, Viale P.   +6 more
europepmc   +1 more source

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort

HIV Medicine, Volume 26, Issue 6, Page 970-977, June 2025.
Abstract Objectives Most treatment switches are for simplification from three‐drug (3DR) to dual regimens (2DR). However, a proportion of people with HIV may switch back to 3DR, like bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) after 2DR.
Andrea De Vito, Alessandro Tavelli, Alessandro Cozzi‐Lepri, Andrea Giacomelli, Roberto Rossotti, Giacomo Ponta, Nicoletta Bobbio, Alice Ianniello, Antonella Cingolani, Giordano Madeddu, Andrea Antinori, Antonella d'Arminio Monforte, on behalf of ICONA Foundation Study Group, A. d'Arminio Monforte, A. Antinori, S. Antinori, A. Castagna, R. Cauda, G. Di Perri, E. Girardi, R. Iardino, A. Lazzarin, G. C. Marchetti, C. Mussini, E. Quiros‐Roldan, L. Sarmati, B. Suligoi, F. Von Schloesser, P. Viale, A. d'Arminio Monforte, A. Antinori, A. Castagna, F. Ceccherini‐Silberstein, A. Cingolani, A. Cozzi‐Lepri, A. Di Biagio, E. Girardi, A. Gori, S. Lo Caputo, G. Marchetti, F. Maggiolo, C. Mussini, M. Puoti, C. F. Perno, C. Torti, A. Antinori, A. Bandera, S. Bonora, A. Calcagno, D. Canetti, A. Castagna, F. Ceccherini‐Silberstein, A. Cervo, A. Cingolani, P. Cinque, A. Cozzi‐Lepri, A. d'Arminio Monforte, A. Di Biagio, R. Gagliardini, A. Giacomelli, E. Girardi, N. Gianotti, A. Gori, G. Guaraldi, S. Lanini, G. Lapadula, M. Lichtner, A. Lai, S. Lo Caputo, G. Madeddu, F. Maggiolo, V. Malagnino, G. Marchetti, A. Mondi, V. Mazzotta, C. Mussini, S. Nozza, C. F. Perno, S. Piconi, C. Pinnetti, M. Puoti, E. Quiros Roldan, R. Rossotti, S. Rusconi, M. M. Santoro, A. Saracino, L. Sarmati, V. Spagnuolo, N. Squillace, V. Svicher, L. Taramasso, C. Torti, A. Vergori, A. Cozzi‐Lepri, S. De Benedittis, I. Fanti, M. Giotta, C. Marelli, A. Rodano, A. Tavelli, M. Cernuschi, L. Cosmaro, A. Perziano, V. Calvino, D. Russo, M. Farinella, N. Policek, V. L. Del Negro, M. Augello, S. Carrara, S. Graziano, G. Prota, S. Truffa, D. Vincenti, R. Rovito, M. Sgarlata, I. A Giacometti, A. Costantini, V. Barocci, A. Saracino, C. Santoro, E. Milano, L. Comi, C. Suardi, P. Viale, L. Badia, S. Cretella, E. M. Erne, A. Pieri, E. Quiros Roldan, E. Focà, B. Menzaghi, C. Abeli, L. Chessa, F. Pes, P. Maggi, L. Alessio, G. Nunnari, B. M. Celesia, J. Vecchiet, K. Falasca, A. Pan, S. Dal Zoppo, D. Segala, F. Bartalesi, C. Costa, S. Lo Caputo, S. Ferrara, M. Bassetti, E. Pontali, S. Blanchi, N. Bobbio, C. Del Borgo, R. Marocco, G. Mancarella, S. Piconi, C. Molteni, S. Rusconi, G. Canavesi, G. Pellicanò, G. Marchetti, S. Antinori, G. Rizzardini, M. Puoti, A. Castagna, A. Bandera, V. Bono, M. V. Cossu, A. Giacomelli, R. Lolatto, M. C. Moioli, L. Pezzati, S. Diotallevi, C. Tincati, C. Mussini, M. Menozzi, P. Bonfanti, G. Lapadula, V. Sangiovanni, I. Gentile, V. Esposito, N. Coppola, F. M. Fusco, G. Di Filippo, V. Rizzo, N. Sangiovanni, S. Martini, A. M. Cattelan, D. Leoni, A. Cascio, M. Trizzino, D. Francisci, E. Schiaroli, G. Parruti, F. Sozio, D. Messeri, S. I. Bonelli, C. Lazzaretti, R. Corsini, A. Antinori, R. Cauda, C. Mastroianni, L. Sarmati, A. Latini, A. Cingolani, I. Mastrorosa, S. Lamonica, M. Capozzi, M. Camici, I. Mezzaroma, M. Rivano Capparuccia, G. Iaiani, C. Stingone, L. Gianserra, J. Paulicelli, M. M. Plazzi, G. d'Ettore, M. Fusto, M. Lichtner, I. Coledan, G. Madeddu, A. De Vito, M. Fabbiani, F. Montagnani, A. Franco, R. Fontana Del Vecchio, D. Francisci, C. Di Giuli, G. C. Orofino, G. Calleri, G. Di Perri, S. Bonora, G. Accardo, C. Tascini, A. Londero, G. Battagin, S. Nicolè, G. Starnini, S. Dell'Isola   +238 more
wiley   +1 more source

Effectiveness and Pitfalls of Initial Highly Active Antiretroviral Therapy in HIV-Infected Patients in Routine Clinical Practice [PDF]

, 2000
Ana Moreno, Marı́a Jesús Pérez-Elı́as, José L. Casado, Vicente Muñoz, Antonio Antela, Fernando Dronda, Enrique Navas, Jesús Fortün, Carmen Quereda, Santiago Moreno   +9 more
openalex   +1 more source

Inflammatory Nail Disorders in Skin of Color: A Systematic Review of Clinical and Onychoscopic Manifestations

International Journal of Dermatology, Volume 64, Issue 6, Page 1013-1020, June 2025.
ABSTRACT Despite increasing attention regarding skin diseases in individuals with skin of color (SoC), there remains a significant gap in understanding and identifying inflammatory nail disorders in this population. This systematic review aims to synthesize the clinical and onychoscopic features of inflammatory nail disorders in patients with SoC ...
Lea Tordjman, Jason Thomas, Antonella Tosti, Brian W. Morrison   +3 more
wiley   +1 more source

Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background and Aims: Drug‐induced liver injury (DILI) remains a leading cause of acute liver failure worldwide. Drugs such as isoniazid, alone or in combination with other anti‐tuberculosis drugs, as well as a growing number of herbal and complementary medicines, have been implicated in most cases of acute liver failure in registry studies ...
Harshad C. Devarbhavi, Raúl J. Andrade
wiley   +1 more source

Association between gut microbiota in HIV-infected patients and immune reconstitution following antiretroviral therapy (ART). [PDF]

BMC Infect Dis
Shi Y, Hu M, Wu J, Liu T, Qi Y, Li A.
europepmc   +1 more source

Incidence and predictors of lost to follow up among children receiving antiretroviral therapy a computing risk regression model. [PDF]

Sci Rep
Mekonnen GB, Tilaye BA, Baye FD, Kefale D, Ewunetu M, Aytenew TM, Eshetie Y, Kerebeh G, Emiru TD, Demissie B, Ayen AA, Legesse BT, Wondie WT, Kassaw A, Bazezew LY, Endalew TL, Setargew KH, Baye AA.   +17 more
europepmc   +1 more source

Cryptosporidiosis: eradication or suppression with combination antiretroviral therapy?

, 1999
YongGang Miao, Fatih M. Awad-El-Kariem, C. L. M. H. Gibbons, B G Gazzard   +3 more
openalex   +1 more source

Antiretroviral therapy and HIV-related retinal microangiopathy

, 1997
Paola Pivetti‐Pezzi, Massimo Accorinti, V. Ciapparoni, Vincenzo Vullo, F Aiuti   +4 more
openalex   +1 more source